Investment-In-Innovation (IN3) Medical Device 360 Dublin Adds Big Names to Its
April 16-18, 2013, The Shelbourne Dublin
DUBLIN, IRELAND -- (Marketwire) -- 03/27/13 -- Elsevier Business
Intelligence, publisher of "The Gray Sheet" and the medtech
industry's leading provider of strategic partnership and investment
conferences, will host the 'Investment-in-Innovation (IN3) Medical
Device 360 degrees Dublin' partnering and investment conference on
April 16-18, 2013, at the The Shelbourne Dublin. This special event
will bring together a diverse group of medtech's key thought leaders
from among corporate business development execs, family office,
venture capital and angel investors, start-up entrepreneurs and
industry pioneers. Program highlights will include:
Keynote Address on Behalf of Eucomed Creating Value in European
Healthcare: Transforming the Medtech Business Model to Deliver
Value-Based Innovations: Thierry Herbreteau, President, Europe Middle
East Africa and Canada (EMEAC), St. Jude Medical.
Strategics on Deal Priorities -- Driving Growth through Different
Structures In this interactive session, large device company
executives will share their lessons on how they are driving growth
through M & A.
-- What is the current appetite for deals? Compared to previous years?
-- Thin pickings or window of opportunities? How suitable is the startup
community in creating the environment to do more deals?
-- Building the infrastructure to do more deals.
-- Focusing on revenue-generating companies.
-- Tuck-in acquisitions vs. white space deals: where to focus?
-- Growth through non-traditional markets: which areas can supplement
Confirmed panelists will include: David Cassak (moderator), Vice
President, Content, Elsevier Business Intelligence; Steve Levin
(moderator), Editor-in-Chief, Elsevier Business Intelligence; Amir
Blumenfeld, MD, MHA, Director of Discovery, Edwards Lifesciences;
Chad Cornell, Vice President of Corporate Development, Medtronic;
Dennis Crowley, Senior Vice President, Corporate Development &
Licensing, Covidien; Townsend Goddard, Director of Business
Development & Strategic Planning, Stryker; Tomaso Zambelli, Director
of Corporate Strategy & Business Development, Sorin Group; Zeev
vi, Vice President, Venture Investments, Johnson & Johnson
In addition to all of the customary conference benefits, presenting
company CEOs will have the opportunity to be interviewed on camera,
at no charge, for a 3-minute exclusive video in which they may
discuss their company and technology. These interviews will be
featured post-conference at www.in3tv.com, to which a link will be
provided to participating companies for their unrestricted use;
availability of these video interviews will be broadly promulgated
within the medtech industry. All one-on-one interviews with
presenting-company CEOs will take place at, and during the IN3 Dublin
conference and be organized by medtech PR/IR expert Ronald Trahan,
President of Ronald Trahan Associates, Inc. Videotaping will take
place on a scheduled basis only, on one day only of the event:
Wednesday, April 17, from 13:00-17:30 local time. To schedule the
free on-camera interviews contact firstname.lastname@example.org, or call
IN3 Dublin will feature presentations by 36 early development- to
commercial-stage start-up device companies seeking funding and/or
strategic partnership. Confirmed presenters to date include: Access
Bio, Aerogen, Aleva Neurotherapeutics, AltaScience, APICA
Cardiovascular, Calon Cardio-Technology, CapeRay, Chronix Biomedical,
Crescent Diagnostics, Dialog Devices, Expanding Orthopedics, FBC
Device, Glysure, Humedics, i360medical, Infandx, Life Care Medical
Devices, Mainstay Medical, Mederi Therapeutics, MedLumics, Miracor
Medical Systems, Nano Bridging Molecules, Neuravi, NeuroMed Devices,
Nordocs, Novate Medical, Quanta Fluid Solutions, Regenesis
Biomedical, Respinova, Revision Optics, Simpirica Spine, SpineLab,
Technopath, Vascular Flow Technologies, Veryan Medical, and Vivasure
Event co-sponsors include Ronald Trahan Associates Inc., Aptiv
Solutions, Enterprise Ireland, Eucomed, Eugene F. Collins, IMDA,
KPMG, Life Science Intelligence, Marketwire, MassMEDIC, Mass Medical
Angels, Medmarc. Meditech, Seroba Kernel and Pharma Connections.
Visit www.in3dublin.com for full conference and registration details.
Emerging medtech companies that would like to apply to present in
Dublin should contact Kayleen Kell at 949-797-7142, or email
About Elsevier Business Intelligence
Elsevier Business Intelligence
(EBI), an Elsevier company built on the heritage of F-D-C Reports,
Windhover Information and Medtech Insight, is a global information
supplier providing business intelligence on regulatory, business and
reimbursement issues that are vital to the healthcare industry.
Through a range of products including publications, conferences,
databases and reports, EBI places biopharma and medical device
professionals, and those who focus on these industries, at the
forefront of knowledge, by providing the perfect combination of news
and information together with penetrating insight and analysis. EBI
(www.elsevierbi.com) has offices in the U.S. in Bridgewater, N.J.;
Norwalk, Conn.; Rockville, Md.; and Irvine, Calif.
Ronald Trahan, APR
Ronald Trahan Associates Inc.
Press spacebar to pause and continue. Press esc to stop.